www.fdanews.com/articles/139513-cvrx-receives-ce-mark-approval-and-introduces-new-implantable-device-for-hypertension-the-barostim-neo
CVRx Receives CE Mark Approval and Introduces New Implantable Device for Hypertension, the Barostim Neo
August 25, 2011
CVRx introduced its second-generation implantable device, the Barostim neo, for the treatment of uncontrolled hypertension.
SunHerald
SunHerald